Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection.

Xue, Yan

Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection. [electronic resource] - World journal of gastroenterology Aug 2017 - 5969-5976 p. digital

Publication Type: Journal Article

2219-2840

10.3748/wjg.v23.i32.5969 doi


Adult
Antiviral Agents--therapeutic use
Carbamates
China
Drug Therapy, Combination--methods
Graft Rejection--prevention & control
Hepacivirus--genetics
Hepatitis C, Chronic--complications
Humans
Imidazoles--therapeutic use
Kidney Transplantation--adverse effects
Liver Cirrhosis--prevention & control
Male
Middle Aged
Pilot Projects
Prospective Studies
Pyrrolidines
RNA, Viral--isolation & purification
Ribavirin--therapeutic use
Sofosbuvir--therapeutic use
Transplant Recipients
Treatment Outcome
Valine--analogs & derivatives